diabetes glp 1 agonist GLP-1 Receptor Agonists as Treatments for Type 2 GLP-1R and Diabetes

The washout is shorter at the minimum recommended 20 to 25 days

Their dual benefits in glycaemic control and weight loss have made them an invaluable addition to the therapeutic landscape, yet their influence extends beyond clinical settings, impacting economic, cultural, and social realms (Wang et al., 2024)

At present, there is no evidence to support the use of GLP-1RAs as primary therapy or as adjunctive treatment alongside other advanced therapies specifically for IBD or for IBD patients with metabolic risk factors

SN : Can we say that GLP-1 drugs prevent cancer

Each database permits tracking of healthcare utilization and medication exposure over time, and patients may contribute to more than one database if they meet the respective eligibility criteria